Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Hackensack Meridian Health
National Cancer Institute (NCI)
University of Rochester
Medical College of Wisconsin
Shattuck Labs, Inc.
Orca Biosystems, Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Gamida Cell ltd
City of Hope Medical Center
NextCure, Inc.
Brown University
Novartis
Geron Corporation
Dana-Farber Cancer Institute
Montefiore Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
Thomas Jefferson University
Baylor College of Medicine
Takeda
Incyte Corporation
Incyte Corporation
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Stanford University
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Children's Oncology Group
Amgen
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute